PO.CL05.10 · 临床研究

应激诱导的失巢凋亡抵抗触发子宫平滑肌瘤细胞的类恶性表型

Stress-induced anoikis-resistance triggers malignant-like phenotypes in uterine leiomyoma cells

海报缩略图:应激诱导的失巢凋亡抵抗触发子宫平滑肌瘤细胞的类恶性表型
编号 7939 展板 14 时间 4/22 09:00–12:00 区域 Section 49 主讲 Katia Carvalho, PhD
分会场 Tumor Microenvironment Modulators
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Roseli da Silva Soares1, Edmund C. Baracat2, Katia C. Carvalho3

1University of São Paulo, Faculty of Medicine, São Paulo, Brazil,2Sao Paulo University, Sao Paulo, Brazil,3Obstetrics and Gynecology, HCFMUSP, Sao Paulo, Brazil

摘要 Abstract

中文摘要
背景:子宫平滑肌瘤(LM)是育龄女性中最常见的肿瘤,构成重大临床负担。尽管LM通常被视为良性,但一个长期存在的科学问题是,其中一部分肿瘤是否可能发生恶性转化为平滑肌肉瘤(LMS)——一种罕见但高度侵袭性的子宫肉瘤。迄今为止,这一进展尚未得到确凿证实,但也不能完全排除,而可能促成此类转化的生物学机制仍知之甚少。失巢凋亡抵抗——即细胞在丧失细胞外基质附着后存活的能力——是多种实体瘤中恶性转化和早期转移行为的标志。因此,诱导失巢凋亡抵抗的实验模型可能为了解LM细胞能否在持续细胞应激下获得类恶性特征提供线索。 方法:将子宫肌层(MM;PCS-460-011)和平滑肌瘤(LM;THESCs;CRL-4003)的已建系细胞(1×10⁵个细胞/mL)接种于包被1%无菌琼脂糖的培养板上以防止细胞-基质黏附,并在37℃、5% CO₂条件下维持96小时。收集存活的非贴壁球体(失巢凋亡抵抗细胞)并在贴壁条件下重新接种。该球体形成周期重复四次,产生衍生细胞群LM1C、LM2C、LM3C和LM4C。随后,将球体进行有限稀释以获得克隆群体。随机选取五个克隆进行扩增及功能/分子分析。 结果:初步结果表明,LM细胞逐渐丧失黏附能力并获得失巢凋亡抵抗,同时伴有显著的表型改变。MM细胞未能在反复阻断黏附的周期中存活,并在第5周期(C5)前被淘汰,而LM细胞成功地贯穿所有周期存活。克隆扩增后,通过测序确认了遗传身份,验证了其LM来源。克隆形成实验显示出显著的行为变化:与亲本LM细胞相比,失巢凋亡抵抗的LM衍生细胞表现出在不依赖细胞间接触的情况下存活和增殖的能力增强。正在进行的增殖、迁移和侵袭实验进一步提示体外存在重要的表型和行为改变。 结论:失巢凋亡抵抗模型似乎是研究子宫平滑肌瘤生物学的有价值工具。我们的发现提示,LM细胞在反复黏附应激下可能获得类恶性特征,支持失巢凋亡抵抗可能促进子宫平滑肌肿瘤恶性转化这一假说。
查看英文原文 English abstract
Background: Uterine leiomyomas (LM) are the most common tumors in women of reproductive age and represent a major clinical burden. Although LM are classically considered benign, a long-standing scientific question concerns whether a subset of these tumors may undergo malignant transformation into leiomyosarcomas (LMS), a rare but highly aggressive uterine sarcoma. To date, this progression has not been conclusively demonstrated, yet it also cannot be fully excluded, and the biological mechanisms that might enable such a transition remain poorly understood. Anoikis resistance - the capacity of cells to survive loss of extracellular matrix attachment - is a hallmark of malignant transformation and early metastatic behavior in several solid tumors. Therefore, experimental models that induce anoikis resistance may offer insight into whether LM cells can acquire malignant-like traits under sustained cellular stress. Methods: Established cell lines of myometrium (MM; PCS-460-011) and leiomyoma (LM; THESCs; CRL-4003) were cultured (1×10⁵ cells/mL) on plates coated with 1% sterile agarose to prevent cell-matrix adhesion and maintained for 96 hours at 37°C and 5% CO₂. Surviving non-adherent spheroids (anoikis-resistant cells) were collected and replated under adherent conditions. This spheroid-formation cycle was repeated four times, generating the derived cell populations LM1C, LM2C, LM3C, and LM4C. Subsequently, spheroids were subjected to limiting dilution to obtain clonal populations. Five clones were randomly selected for expansion and functional/molecular analyses. Results: Preliminary findings indicate that LM cells progressively lose adhesion capacity and acquire anoikis resistance, accompanied by notable phenotypic alterations. MM cells did not survive repeated adhesion-blocking cycles and were eliminated before cycle 5 (C5), whereas LM cells successfully persisted through all cycles. After clonal expansion, genetic identity was confirmed through sequencing, validating their LM origin. Clonogenic assays demonstrated significant behavioral changes: anoikis-resistant LM derivatives exhibited an increased ability to survive and proliferate independently of cell-cell contact compared with parental LM cells. Ongoing assays of proliferation, migration, and invasion further indicate important phenotypic and behavioral alterations in vitro. Conclusion: The anoikis-resistance model appears to be a valuable tool for studying uterine leiomyoma biology. Our findings suggest that LM cells may acquire malignant-like traits when subjected to repeated adhesion stress, supporting the hypothesis that anoikis resistance may contribute to malignant transformation in uterine smooth muscle tumors.
利益披露 Disclosure
K. C. Carvalho, None.

← 返回 AACR 2026 检索